
Randeep Singh
Examiner (ID: 377)
| Most Active Art Unit | 1615 |
| Art Unit(s) | 1615 |
| Total Applications | 524 |
| Issued Applications | 328 |
| Pending Applications | 7 |
| Abandoned Applications | 192 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16663785
[patent_doc_number] => 10933007
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-02
[patent_title] => Composition comprising the combination of specific alkoxysilanes and of a surfactant
[patent_app_type] => utility
[patent_app_number] => 16/061858
[patent_app_country] => US
[patent_app_date] => 2016-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7747
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 285
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16061858
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/061858 | Composition comprising the combination of specific alkoxysilanes and of a surfactant | Dec 13, 2016 | Issued |
Array
(
[id] => 13729243
[patent_doc_number] => 20180369089
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-27
[patent_title] => COSMETIC COMPOSITION COMPRISING AN ANIONIC SURFACTANT, AT LEAST 3.5% BY WEIGHT OF A FATTY ACID AND AN ANTIDANDRUFF AGENT
[patent_app_type] => utility
[patent_app_number] => 16/062268
[patent_app_country] => US
[patent_app_date] => 2016-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11704
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16062268
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/062268 | Cosmetic composition comprising an anionic surfactant, at least 3.5% by weight of a fatty acid and an antidandruff agent | Dec 12, 2016 | Issued |
Array
(
[id] => 11704295
[patent_doc_number] => 20170172794
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-22
[patent_title] => 'Reservoir Device for Intraocular Drug Delivery'
[patent_app_type] => utility
[patent_app_number] => 15/366982
[patent_app_country] => US
[patent_app_date] => 2016-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6853
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15366982
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/366982 | Reservoir Device for Intraocular Drug Delivery | Nov 30, 2016 | Abandoned |
Array
(
[id] => 11662447
[patent_doc_number] => 20170151149
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-01
[patent_title] => 'TOPICAL SKIN COMPOSITIONS HAVING PROTEINS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 15/365045
[patent_app_country] => US
[patent_app_date] => 2016-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 38153
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15365045
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/365045 | TOPICAL SKIN COMPOSITIONS HAVING PROTEINS AND METHODS OF USE | Nov 29, 2016 | Abandoned |
Array
(
[id] => 11809066
[patent_doc_number] => 09713624
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2017-07-25
[patent_title] => 'Synthesis of rutin nanotubes'
[patent_app_type] => utility
[patent_app_number] => 15/364225
[patent_app_country] => US
[patent_app_date] => 2016-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 16
[patent_no_of_words] => 1776
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15364225
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/364225 | Synthesis of rutin nanotubes | Nov 28, 2016 | Issued |
Array
(
[id] => 11497929
[patent_doc_number] => 20170072115
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-16
[patent_title] => 'DRUG ELUTING COMPOSITE'
[patent_app_type] => utility
[patent_app_number] => 15/362008
[patent_app_country] => US
[patent_app_date] => 2016-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 40
[patent_no_of_words] => 12065
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15362008
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/362008 | Drug eluting composite | Nov 27, 2016 | Issued |
Array
(
[id] => 11491339
[patent_doc_number] => 20170065524
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-09
[patent_title] => 'Pharmaceutical Formulation Containing Gelling Agent'
[patent_app_type] => utility
[patent_app_number] => 15/354473
[patent_app_country] => US
[patent_app_date] => 2016-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20326
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15354473
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/354473 | Pharmaceutical Formulation Containing Gelling Agent | Nov 16, 2016 | Abandoned |
Array
(
[id] => 11491340
[patent_doc_number] => 20170065525
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-09
[patent_title] => 'Pharmaceutical Formulation Containing Gelling Agent'
[patent_app_type] => utility
[patent_app_number] => 15/354538
[patent_app_country] => US
[patent_app_date] => 2016-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20325
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15354538
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/354538 | Pharmaceutical formulation containing gelling agent | Nov 16, 2016 | Issued |
Array
(
[id] => 15708513
[patent_doc_number] => 20200101022
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-02
[patent_title] => FORMULATIONS OF CYSTEAMINE AND CYSTAMINE
[patent_app_type] => utility
[patent_app_number] => 16/461361
[patent_app_country] => US
[patent_app_date] => 2016-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7974
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16461361
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/461361 | Formulations of cysteamine and cystamine | Nov 15, 2016 | Issued |
Array
(
[id] => 15949011
[patent_doc_number] => 10662395
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-26
[patent_title] => Odor neutralizer for ammonia and primary or secondary amines
[patent_app_type] => utility
[patent_app_number] => 15/768054
[patent_app_country] => US
[patent_app_date] => 2016-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 7136
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15768054
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/768054 | Odor neutralizer for ammonia and primary or secondary amines | Nov 15, 2016 | Issued |
Array
(
[id] => 15694355
[patent_doc_number] => 10603338
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-31
[patent_title] => Method for poly signal activation of apoptosis of malignant solid tumour cells
[patent_app_type] => utility
[patent_app_number] => 15/757285
[patent_app_country] => US
[patent_app_date] => 2016-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4014
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 154
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15757285
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/757285 | Method for poly signal activation of apoptosis of malignant solid tumour cells | Oct 20, 2016 | Issued |
Array
(
[id] => 11567351
[patent_doc_number] => 20170105996
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-20
[patent_title] => 'TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE OR NON-ALCOHOLIC STEATOHEPATITIS WITH DELAYED-RELEASE 6-MERCAPTOPURINE'
[patent_app_type] => utility
[patent_app_number] => 15/294075
[patent_app_country] => US
[patent_app_date] => 2016-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 20537
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15294075
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/294075 | TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE OR NON-ALCOHOLIC STEATOHEPATITIS WITH DELAYED-RELEASE 6-MERCAPTOPURINE | Oct 13, 2016 | Abandoned |
Array
(
[id] => 16320152
[patent_doc_number] => 10780099
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-22
[patent_title] => Injectable neurosteroid formulations containing nanoparticles
[patent_app_type] => utility
[patent_app_number] => 15/294135
[patent_app_country] => US
[patent_app_date] => 2016-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 17
[patent_no_of_words] => 16124
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15294135
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/294135 | Injectable neurosteroid formulations containing nanoparticles | Oct 13, 2016 | Issued |
Array
(
[id] => 12143689
[patent_doc_number] => 09877924
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-01-30
[patent_title] => 'Pharmaceutical formulation containing gelling agent'
[patent_app_type] => utility
[patent_app_number] => 15/284706
[patent_app_country] => US
[patent_app_date] => 2016-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20544
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15284706
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/284706 | Pharmaceutical formulation containing gelling agent | Oct 3, 2016 | Issued |
Array
(
[id] => 13457509
[patent_doc_number] => 20180280297
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-04
[patent_title] => NO-RINSE CHEMICAL FOAM CONTAINING TRIFAROTENE, AND USE THEREOF IN THE TREATMENT OF ACNE
[patent_app_type] => utility
[patent_app_number] => 15/763685
[patent_app_country] => US
[patent_app_date] => 2016-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8391
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15763685
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/763685 | No-rinse chemical foam containing trifarotene, and use thereof in the treatment of acne | Sep 26, 2016 | Issued |
Array
(
[id] => 13457511
[patent_doc_number] => 20180280298
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-04
[patent_title] => NO-RINSE CHEMICAL FOAM CONTAINING TRIFAROTENE, AND USE THEREOF IN THE TREATMENT OF ICHTHYOSIS
[patent_app_type] => utility
[patent_app_number] => 15/763753
[patent_app_country] => US
[patent_app_date] => 2016-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8693
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15763753
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/763753 | No-rinse chemical foam containing trifarotene, and use thereof in the treatment of ichthyosis | Sep 26, 2016 | Issued |
Array
(
[id] => 13397385
[patent_doc_number] => 20180250235
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-06
[patent_title] => FINGOLIMOD CAPSULE COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 15/760550
[patent_app_country] => US
[patent_app_date] => 2016-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2139
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15760550
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/760550 | FINGOLIMOD CAPSULE COMPOSITION | Sep 15, 2016 | Abandoned |
Array
(
[id] => 13672821
[patent_doc_number] => 20160375144
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-29
[patent_title] => METAP-2 INHIBITOR POLYMERSOMES FOR THERAPEUTIC ADMINISTRATION
[patent_app_type] => utility
[patent_app_number] => 15/262143
[patent_app_country] => US
[patent_app_date] => 2016-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39264
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15262143
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/262143 | MetAP-2 inhibitor polymersomes for therapeutic administration | Sep 11, 2016 | Issued |
Array
(
[id] => 15173893
[patent_doc_number] => 20190357538
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-28
[patent_title] => An Antifungal Composition Comprising Natamycin and C4-C22 Fatty Acids, Monoglycerides of These Fatty Acids and/or Derivatives of These Fatty Acids
[patent_app_type] => utility
[patent_app_number] => 15/759026
[patent_app_country] => US
[patent_app_date] => 2016-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14226
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15759026
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/759026 | An Antifungal Composition Comprising Natamycin and C4-C22 Fatty Acids, Monoglycerides of These Fatty Acids and/or Derivatives of These Fatty Acids | Sep 8, 2016 | Abandoned |
Array
(
[id] => 11335672
[patent_doc_number] => 20160361428
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-15
[patent_title] => 'METAP-2 INHIBITOR POLYMERSOMES FOR THERAPEUTIC ADMINISTRATION'
[patent_app_type] => utility
[patent_app_number] => 15/248043
[patent_app_country] => US
[patent_app_date] => 2016-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 43652
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15248043
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/248043 | MetAP-2 inhibitor polymersomes for therapeutic administration | Aug 25, 2016 | Issued |